「Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model」の関連論文
-
T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation
-
Aging-associated and CD4 T-cell–dependent ectopic CXCL13 activation predisposes to anti–PD-1 therapy-induced adverse events
-
TSC22D4/THG-1 suppresses cellular senescence in esophageal squamous cell carcinoma
-
STAT3 induces hypoxic preconditioning against oxidative stress in neural stem cells
-
Nrf2/p-Fyn/ABCB1 axis accompanied by p-Fyn nuclear accumulation plays pivotal roles in vinorelbine resistance in non-small cell lung cancer
-
CXCR4 in tumor epithelial cells mediates desmoplastic reaction in pancreatic ductal adenocarcinoma
-
Study on the regulation of CD8+ T cell immune response through nuclear receptor RORα and REV-ERB [an abstract of entire text]
-
Comparison of cytoreductive surgery and resection of isolated peritoneal metastases in patients with peritoneal metastases from colorectal cancer: a retrospective study
-
Third-look endoscopy prevents delayed bleeding after endoscopic submucosal dissection under antithrombotic therapy
-
A study on the immunostimulatory effects of alarmin HMGN1 in cancer immunity
-
Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients
-
The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry
-
Albumin-Globulin Ratio Indicates the Survival Outcome of Pancreatic Cancer Cases Who Underwent Preoperative Treatment and Curative Surgical Resection
-
Tumour-immune microenvironment in duodenal-type follicular lymphoma
-
Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma
-
Irbesartan, an angiotensin II type 1 receptor blocker, inhibits colitis-associated tumourigenesis by blocking the MCP-1/CCR2 pathway
-
Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients
-
Clinical significance of BIM deletion polymorphism on chemoradiotherapy in patients with non-small cell lung cancer.
-
Clinical significance of BIM deletion polymorphism on chemoradiotherapy in patients with non-small cell lung cancer.
-
Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas : significance of cell adhesion and epithelial–mesenchymal transition-related signaling pathways (本文)
-
Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease
-
The ATR inhibitor AZD6738 increases the sensitivity of 5-fluorouracil in colorectal cancer cells by abrogating repair of DNA damage
-
Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma (本文)
-
Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models
-
Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin
-
Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing (本文)
-
Development of an in vitro carcinogenesis model of human papillomavirus-induced cervical adenocarcinoma (本文)
-
Generation of molecular-targeting peptides for selective inhibition of the interaction between CTLA-4 and B7 in the dog: a new immune checkpoint inhibitor for cancer therapy
-
卵巣低異型度漿液性癌のin vitro発癌モデル
-
Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemia
-
Characterization of cisplatin effects in lenvatinib‐resistant hepatocellular carcinoma cells
-
PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma
-
Latest classification of ependymoma in the molecular era and advances in its treatment: a review
-
Serum amyloid alpha 1-2 are not required for liver inflammation in the 4T1 murine breast cancer model
-
GSK3 inhibitor enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells by overcoming multiple mechanisms of resistance
-
Antitumor Effect of Sclerostin against Osteosarcoma
-
A case of metastatic prostate cancer treated with metastasectomy
-
Compromised anti-tumor–immune features of myeloid cell components in chronic myeloid leukemia patients
-
Pluripotent stem cell-based therapies and their path to the clinic
-
Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix
-
Immune checkpoint inhibitors for patients with pre-existing autoimmune diseases
-
The Roles of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis
-
Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion
-
Diverse antitumor effects of ascorbic acid on cancer cells and the tumor microenvironment
-
CD204‑positive macrophages accumulate in breast cancer tumors with high levels of infiltrating lymphocytes and programmed death ligand‑1 expression
-
The fruits of CD40 research in basic and clinical medicine will soon be harvested
-
Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
-
Identification of T cell receptors targeting a neoantigen derived from recurrently mutated FGFR3
-
Association of CD4-positive cell infiltration with response to vedolizumab in patients with ulcerative colitis
-
Sessile serrated lesions with dysplasia: is it possible to nip them in the bud?